A study found that people with metabolic syndrome are 1.5 times more likely to develop a stroke than those without it, with women being 2.1 times more at risk. The condition is also associated with an increased risk of heart attacks and vascular-related deaths.
Researchers found that CRP levels above 3.0mg/L significantly increased the risk of heart attacks, strokes, and death from cardiovascular disease in women with metabolic syndrome. Higher CRP levels were also associated with higher cardiovascular risk, even among those with lower CRP levels.
In a large clinical trial, patients with impaired glucose tolerance who took acarbose were 25% less likely to develop type-2 diabetes than those taking placebo. Acarbose also helped reversion of impaired glucose tolerance to normal glucose tolerance. The main side effects were flatulence and diarrhea.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A new study from the University of North Carolina at Chapel Hill found that Australian Aboriginals are more susceptible to diabetes due to excess weight. The researchers suggest lowering BMI guidelines to reduce the risk, which could potentially prevent up to 46% of diabetes cases.
A study published in Psychosomatic Medicine found that chronic stress is associated with an increased risk of heart disease in men. The research, led by Peter P. Vitaliano, identified a general pattern connecting chronic stress to heart disease, including poor health habits and changes in body composition and metabolism.
Researchers found a link between polycystic ovary syndrome and increased coronary artery calcification, an early indicator of cardiovascular disease. Addressing insulin sensitivity and central obesity may reduce this risk in young women with PCOS.
A study of 254 women with Polycystic Ovary Syndrome (PCOS) found that 7.5% had undiagnosed diabetes, compared to 1% in the general population. Insulin resistance is a key factor in PCOS-related glucose intolerance and diabetes risk.